
    
      A phase III, randomized, double-blind, placebo-controlled, multicenter, 7-month study
      designed to assess the safety and efficacy of intramuscular (IM) injections in the calf of
      VM202 in patients with chronic nonhealing foot ulcers. Three hundred patients will be
      randomized in a 2:1 ratio of VM202 or placebo injections:

        -  Active -VM202 + standard of care - 200 patients

        -  Control - Placebo (VM202 Vehicle) + standard of care - 100 patients
    
  